Rapid and Scalable Characterization of CRISPR Technologies Using an E. coli Cell-Free Transcription-Translation System
- PMID: 29304331
- PMCID: PMC5976856
- DOI: 10.1016/j.molcel.2017.12.007
Rapid and Scalable Characterization of CRISPR Technologies Using an E. coli Cell-Free Transcription-Translation System
Abstract
CRISPR-Cas systems offer versatile technologies for genome engineering, yet their implementation has been outpaced by ongoing discoveries of new Cas nucleases and anti-CRISPR proteins. Here, we present the use of E. coli cell-free transcription-translation (TXTL) systems to vastly improve the speed and scalability of CRISPR characterization and validation. TXTL can express active CRISPR machinery from added plasmids and linear DNA, and TXTL can output quantitative dynamics of DNA cleavage and gene repression-all without protein purification or live cells. We used TXTL to measure the dynamics of DNA cleavage and gene repression for single- and multi-effector CRISPR nucleases, predict gene repression strength in E. coli, determine the specificities of 24 diverse anti-CRISPR proteins, and develop a fast and scalable screen for protospacer-adjacent motifs that was successfully applied to five uncharacterized Cpf1 nucleases. These examples underscore how TXTL can facilitate the characterization and application of CRISPR technologies across their many uses.
Keywords: Cas9; Cascade; Cpf1; PAM; TXTL; prototyping; synthetic biology.
Copyright © 2017 Elsevier Inc. All rights reserved.
Conflict of interest statement
C.L.B. is a co-founder and scientific advisory board member of Locus Biosciences and submitted provisional patent applications on CRISPR technologies. M.B.B., B.N.G., E.J., A.S., and Y.H. are current employees of Benson Hill Biosystems, which has proprietary CRISPR technologies on which patent applications have been filed. Noireaux laboratory receives research funds from Arbor Biosciences, a distributor of myTXTL cell-free protein expression kit.
Figures
References
-
- Barrangou R, Doudna JA. Applications of CRISPR technologies in research and beyond. Nat Biotechnol. 2016;34:933–941. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous
